Medicine and Health

A universal dual mechanism immunotherapy for the treatment of influenza virus infections

X. Liu, B. Zhang, et al.

This groundbreaking study reveals a novel bifunctional small molecule that combines the power of the neuraminidase inhibitor zanamivir with the immunogenic hapten dinitrophenyl (DNP). The findings demonstrate its capability to not only inhibit virus release but also to activate immune responses to eliminate both free viruses and infected cells. Conducted by a team of researchers at Purdue University, this research showcases potential treatments for influenza A and B infections that are resistant to current therapies.